Incyte Q1 Results Top Estimates

RTTNews | 1186 days ago
Incyte Q1 Results Top Estimates

(RTTNews) - Incyte Corp. (INCY) on Tuesday reported net income of $161.43 million or $0.72 per share for the first quarter, up from $149.46 million or $0.67 per share in the prior-year quarter.

Excluding items, adjusted net income for the quarter was $1.01 per share, compared to $0.80 per share in the year-ago quarter.

Total revenues for the quarter rose 29 percent to $911.40 million from $705.71 million in the same quarter last year.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.76 per share on revenues of $818.49 million for the quarter. Analysts' estimates typically exclude special items.

Looking ahead to fiscal 2022, Incyte now projects Jakafi net product revenue in a range of $2.36 billion to $2.40 billion. Other Hematology/Oncology net product revenues are projected between $210 million and $240 million.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

read more
Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Corp. (INCY) on Tuesday reported net income of $201.10 million or $0.89 per share for the fourth quarter, sharply higher than $28.46 million or $0.13 per share in the prior-year quarter.
RTTNews | 626 days ago
Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

Incyte Corp. (INCY) announced Friday that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor, for once-daily (QD) use in the treatment of certain types of myelofibrosis (MF), polycythemia vera (PV) and graft-versus-host disease (GVHD).
RTTNews | 952 days ago
DAX Drops To 2-month Low

DAX Drops To 2-month Low

German stocks are down in negative territory on Friday and the benchmark DAX is near two-month lows, as investors, assessing the recent interest rate decisions of the major central banks, and the developments on the trade front, remain cautious and mostly making cautious moves.
RTTNews | 20 minutes ago
European Shares Subdued Before Key Inflation Reading

European Shares Subdued Before Key Inflation Reading

European stocks drifted lower on Friday, and the euro consolidated losses ahead of key Eurozone inflation data due later in the day. Earlier in the day, data showed that French consumer price inflation slowed further below the European Central Bank's target in October despite an unexpectedly strong upswing in the economy.
RTTNews | 1h 48min ago
Asian Shares Mixed; Nikkei Sets New Record As Tech Stocks Surge

Asian Shares Mixed; Nikkei Sets New Record As Tech Stocks Surge

Asian stocks ended mixed on Friday, with Japan's Nikkei hitting a record high on the back of a weaker yen and strong gains in the tech sector while Chinese and Hong Kong markets retreated after a survey showed China's factory activity shrank for a seventh month in October.
RTTNews | 2h 6min ago
Japan Industrial Output Rebounds; Tokyo Inflation Accelerates

Japan Industrial Output Rebounds; Tokyo Inflation Accelerates

Japan's industrial production rebounded at a stronger-than-expected pace at the end of the third quarter and inflation in Tokyo accelerated further in October, official data revealed Friday. Industrial output advanced 2.2 percent month-on-month, in contrast to the 1.5 percent drop in August, the Ministry of Economy, Trade and Industry said. Output was forecast to grow moderately by 1.5 percent.
RTTNews | 4h 0min ago